Br J Ophthalmol 2000;84:1162-1169
( October )
Vasoproliferative tumours of the retina
Heinrich Heimanna, Norbert Bornfeldb, Oliver Vijb, Sarah E Couplandc, Nikolaos E Bechrakisa, Ulrich Kellnera, Michael H Foerstera
a Department of
Ophthalmology, University Hospital Benjamin Franklin, Free University,
Berlin, Germany, b Department of
Ophthalmology, University Hospital, Essen, Germany, c Department of Pathology,
University Hospital Benjamin Franklin, Free University, Berlin, Germany
Correspondence to: Dr Heinrich
Heimann, Augenklinik, University Hospital Benjamin Franklin,
Hindenburgdamm 30, D-12200 Berlin, Germany
heimann{at}ukbf.fu-berlin.de
Accepted for publication 16 May 2000
BACKGROUND Vasoproliferative
tumours of the retina (VPTR) are benign tumours of unknown origin,
occurring mostly in otherwise healthy patients. VPTR may be associated
with other chorioretinal diseases, such as uveitis. The tumours, which
histologically represent reactive gliovascular proliferations, are
characterised by a pink to yellow appearance on funduscopy and are
accompanied by exudative and haemorrhagic changes of the retina.
METHODS 22 cases of
VPTR in 21 patients were examined with a follow up period between 1 month and 6 years. Ophthalmological changes associated with VPTR were
intraretinal and subretinal exudations (n=18), exudative detachments of
the surrounding sensory retina (n=13), intraretinal and subretinal
haemorrhages (n=10), exudative changes within the macula (n=10),
hyperpigmentation of the retinal pigment epithelium at the border of
the exudative retinal changes (n=9), and vitreous haemorrhages (n=4).
Tumour biopsy was performed in two cases. Treatment consisted of plaque
radiotherapy (n=14), plaque radiotherapy and cryotherapy (two),
cryotherapy only (two), observation (three), and enucleation in one
case of a blind and painful eye.
RESULTS Regression of
the tumour and the associated exudative changes could be observed in
all treated cases. Visual acuity at last follow up improved two lines
or more in two cases, remained within two lines of the initial visual
acuity in 15 cases, and worsened in the remaining five.
Histopathological examination of the biopsy specimens and the tumour of
the enucleated eye showed massive capillary proliferation with
perivascular spindle-shaped glial cells of retinal origin.
CONCLUSION The correct
diagnosis of VPTR is of importance as these lesions may lead to visual
loss. Further, VPTR must be differentiated from angiomas associated
with von Hippel-Lindau disease as well as from ocular and systemic
malignancies. Regression of tumour thickness and associated retinal
changes can be achieved with brachytherapy or cryotherapy.
© 2000 by British Journal of Ophthalmology
This article has been cited by other articles:

|
 |

|
 |
 
V. M. L. Cohen, C. L. Shields, H. Demirci, and J. A. Shields
Iodine I 125 Plaque Radiotherapy for Vasoproliferative Tumors of the Retina in 30 Eyes
Arch Ophthalmol,
September 1, 2008;
126(9):
1245 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Damato
Vasoproliferative retinal tumour.
Br. J. Ophthalmol.,
April 1, 2006;
90(4):
399 - 400.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Anastassiou, N Bornfeld, A O Schueler, H Schilling, S Weber, D Fluehs, B Jurklies, O Vij, and W Sauerwein
Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.
Br. J. Ophthalmol.,
April 1, 2006;
90(4):
447 - 450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wachtlin, H. Heimann, C. Jandeck, K. M. Kreusel, N. E. Bechrakis, U. Kellner, and M. H. Foerster
Bilateral Vasoproliferative Retinal Tumors With Identical Localization in a Pair of Monozygotic Twins
Arch Ophthalmol,
June 1, 2002;
120(6):
860 - 862.
[Full Text]
[PDF]
|
 |
|
eLetters:
Read all eLetters
- Intravitreal injection of crystalline cortisone in treatment of retinal vasoproliferative
- Jost B. Jonas, Antje Soefker
- BJO Online, 23 Feb 2001
[Full text]
|
|